$NVDA

Why Nvidia and SpaceX Stocks Are Rising in Premarket Trading Today, Sept. 25

Nvidia (NVDA) and SpaceX (SPCX) stocks rose in premarket trading after Elon Musk announced plans to double Nvidia chips at SpaceX's Colossus 2 data center by year-end. NVDA is up 0.50%, SPCX up 0.70%. Musk aims to add 220,000 more GB300 chips by December, with a target of 1 million GPUs by 2026. The expansion could boost demand for Nvidia's AI chips and support SpaceX's AI infrastructure.

Original reporting
Published Sep 25, 2026, 9:42 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 10:04 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Nvidia and SpaceX Stocks Are Rising in Premarket Trading Today, Sept. 25 — source image
Decision brief

The 30-second read

$NVDABullishMed
01

Why it matters

The announcement provides a fresh, material catalyst that could lift Nvidia's stock ahead of broader market moves.

02

Market read

A pre‑market price increase for Nvidia driven by a new demand signal from SpaceX's AI expansion.

03

What to watch

Potential supply constraints at Nvidia or competing chip suppliers could temper demand.

Relevance 7/10Novelty 6/10Timing: premarket today

Background

Musk's statement ties SpaceX's AI infrastructure growth to Nvidia's GPU portfolio, a key driver for Nvidia's data‑center revenue.

Company-level read

Ticker impact

$NVDABullishMedium confidence
Context

Elon Musk announced SpaceX will double Nvidia chip usage at its Colossus 2 data center, driving a pre‑market price rise.

Expected impact

Modest upside in the next few days as investors price in higher AI‑chip demand.

Evidence & confidence

The announcement is a fresh catalyst linking SpaceX's expansion directly to Nvidia's AI chip sales.

Market effects

Reinforces bullish outlook for the AI‑chip and data‑center sector.

U.S. tech equities may see slight uplift; limited global effect.

Highlights growing demand for high‑performance GPUs worldwide.

Counterpoint

If SpaceX's chip rollout faces delays, the short‑term rally could be overstated.

Key entities

  • Nvidia

    U.S. listed semiconductor maker (NVDA).

  • SpaceX

    Private aerospace firm expanding AI compute capacity.

Related articles

$NVDAHigh

Why Are Chip Stocks Nvidia, AMD, and Broadcom Rising in Pre-Market Today, Sept. 25?

Nvidia (NVDA), AMD (AMD), and Broadcom (AVGO) stocks rose in pre-market trading on Sept. 25, partly due to easing oil prices. Nvidia gained additional support from Elon Musk's announcement that SpaceX will expand its use of Nvidia chips. AMD and Broadcom also benefited from AI infrastructure demand. All three have Strong Buy ratings from analysts, with Broadcom showing the highest upside potential.

$NVDAMed

Nvidia RTX Spark N1X: 6,144 CUDA Cores, Oct. Launch

Nvidia's Arm-based RTX Spark N1X chip, launching in October 2026, combines a Grace CPU with a Blackwell GPU, offering 5,120 or 6,144 CUDA cores and up to 128GB shared memory. It will be used in laptops and compact desktops from multiple OEMs, aiming to compete with Apple, Qualcomm, AMD, and Intel. The chip's high memory usage raises cost concerns amid GPU shortages and rising memory prices, impacting Intel and AMD shares.

Med

Nscale wants a $35 billion valuation. Nvidia is helping foot the bill

Nscale, a two-year-old neocloud company backed by Nvidia, filed for a New York IPO with a valuation of up to $35 billion. The company reported a net loss of $1.02 billion in the first half of 2026 and relies heavily on Nvidia for financing and contracts. Nvidia is a major investor and supplier, raising questions about circular financing. Nscale's IPO could set a benchmark for other AI infrastructure companies.

Low

NVIDIA, Anthropic, Pharma Chiefs Invest in Basecamp Research

Basecamp Research raised $140m in a Series C round led by S32, with NVIDIA, Anthropic, and Roche among investors. The company focuses on AI-designed therapeutics, using its Trillion Gene Atlas dataset to develop personalized treatments. Investors highlight the potential to transform drug manufacturing and innovation.

$LITELow

Why Stocks Should Rebound After Fed Raised Rates

The Fed raised interest rates by 25 basis points, with all FOMC members voting in favor. Initially, the S&P 500 and Nasdaq showed little reaction, but later slumped. Markets recovered in the last hour, except for the Dow Jones, which fell 1.2%. Fed Chair Kevin Warsh suggested a 25 bps hike in November, less than markets expected. Tech stocks Lumentum, Coherent, Intel, and Nvidia saw gains.